pharmaceutical investing Vitality Biopharma Achieves Cannabinoid Pharmaceutical Biosynthesis Breakthrough
Champions Oncology Announces New Collection of Patient-Derived Xenograft (PDX) Models Available for Translational Research
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
